157 related articles for article (PubMed ID: 18057248)
1. Replication of coxsackievirus B3 in primary cell cultures generates novel viral genome deletions.
Kim KS; Chapman NM; Tracy S
J Virol; 2008 Feb; 82(4):2033-7. PubMed ID: 18057248
[TBL] [Abstract][Full Text] [Related]
2. 5'-Terminal deletions occur in coxsackievirus B3 during replication in murine hearts and cardiac myocyte cultures and correlate with encapsidation of negative-strand viral RNA.
Kim KS; Tracy S; Tapprich W; Bailey J; Lee CK; Kim K; Barry WH; Chapman NM
J Virol; 2005 Jun; 79(11):7024-41. PubMed ID: 15890942
[TBL] [Abstract][Full Text] [Related]
3. Functional Consequences of RNA 5'-Terminal Deletions on Coxsackievirus B3 RNA Replication and Ribonucleoprotein Complex Formation.
Lévêque N; Garcia M; Bouin A; Nguyen JHC; Tran GP; Andreoletti L; Semler BL
J Virol; 2017 Aug; 91(16):. PubMed ID: 28539455
[TBL] [Abstract][Full Text] [Related]
4. An infectious cDNA copy of the genome of a non-cardiovirulent coxsackievirus B3 strain: its complete sequence analysis and comparison to the genomes of cardiovirulent coxsackieviruses.
Chapman NM; Tu Z; Tracy S; Gauntt CJ
Arch Virol; 1994; 135(1-2):115-30. PubMed ID: 8198437
[TBL] [Abstract][Full Text] [Related]
5. Coxsackievirus B3 engineered to contain microRNA targets for muscle-specific microRNAs displays attenuated cardiotropic virulence in mice.
He F; Yao H; Wang J; Xiao Z; Xin L; Liu Z; Ma X; Sun J; Jin Q; Liu Z
J Virol; 2015 Jan; 89(2):908-16. PubMed ID: 25339771
[TBL] [Abstract][Full Text] [Related]
6. Mutational Disruption of cis-Acting Replication Element 2C in Coxsackievirus B3 Leads to 5'-Terminal Genomic Deletions.
Smithee S; Tracy S; Chapman NM
J Virol; 2015 Dec; 89(23):11761-72. PubMed ID: 26355088
[TBL] [Abstract][Full Text] [Related]
7. Reversion to wildtype of a mutated and nonfunctional coxsackievirus B3CRE(2C).
Smithee S; Tracy S; Chapman NM
Virus Res; 2016 Jul; 220():136-49. PubMed ID: 27130630
[TBL] [Abstract][Full Text] [Related]
8. Secondary heterotypic versus homotypic infection by Coxsackie B group viruses: impact on early and late histopathological lesions and virus genome prominence.
Yu JZ; Wilson JE; Wood SM; Kandolf R; Klingel K; Yang D; McManus BM
Cardiovasc Pathol; 1999; 8(2):93-102. PubMed ID: 10724506
[TBL] [Abstract][Full Text] [Related]
9. Transgenic expression of replication-restricted enteroviral genomes in heart muscle induces defective excitation-contraction coupling and dilated cardiomyopathy.
Wessely R; Klingel K; Santana LF; Dalton N; Hongo M; Jonathan Lederer W; Kandolf R; Knowlton KU
J Clin Invest; 1998 Oct; 102(7):1444-53. PubMed ID: 9769337
[TBL] [Abstract][Full Text] [Related]
10. Domain I of the 5' non-translated genomic region in coxsackievirus B3 RNA is not required for productive replication.
Jaramillo L; Smithee S; Tracy S; Chapman NM
Virology; 2016 Sep; 496():127-130. PubMed ID: 27289561
[TBL] [Abstract][Full Text] [Related]
11. Persistence of replicating coxsackievirus B3 in the athymic murine heart is associated with development of myocarditic lesions.
Sato S; Tsutsumi R; Burke A; Carlson G; Porro V; Seko Y; Okumura K; Kawana R; Virmani R
J Gen Virol; 1994 Nov; 75 ( Pt 11)():2911-24. PubMed ID: 7964602
[TBL] [Abstract][Full Text] [Related]
12. Major Persistent 5' Terminally Deleted Coxsackievirus B3 Populations in Human Endomyocardial Tissues.
Bouin A; Nguyen Y; Wehbe M; Renois F; Fornes P; Bani-Sadr F; Metz D; Andreoletti L
Emerg Infect Dis; 2016 Aug; 22(8):1488-90. PubMed ID: 27434549
[TBL] [Abstract][Full Text] [Related]
13. Enterovirus-Cardiomyocyte Interactions: Impact of Terminally Deleted Genomic RNAs on Viral and Host Functions.
Bouin A; Vu MN; Al-Hakeem A; Tran GP; Nguyen JHC; Semler BL
J Virol; 2023 Jan; 97(1):e0142622. PubMed ID: 36475766
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of coxsackievirus B3 in cell cultures and in mice by peptide-conjugated morpholino oligomers targeting the internal ribosome entry site.
Yuan J; Stein DA; Lim T; Qiu D; Coughlin S; Liu Z; Wang Y; Blouch R; Moulton HM; Iversen PL; Yang D
J Virol; 2006 Dec; 80(23):11510-9. PubMed ID: 16987987
[TBL] [Abstract][Full Text] [Related]
15. Complete genome sequence of a coxsackievirus B3 isolated from a Sichuan snub-nosed monkey.
He W; Lu H; Zhao K; Song D; Gai X; Gao F
J Virol; 2012 Dec; 86(23):13134-5. PubMed ID: 23118460
[TBL] [Abstract][Full Text] [Related]
16. 5' terminal deletions in the genome of a coxsackievirus B2 strain occurred naturally in human heart.
Chapman NM; Kim KS; Drescher KM; Oka K; Tracy S
Virology; 2008 Jun; 375(2):480-91. PubMed ID: 18378272
[TBL] [Abstract][Full Text] [Related]
17. Characterisation of genomic RNA of Coxsackievirus B3 in murine myocarditis: reliability of direct sequencing of reverse transcription-nested polymerase chain reaction products.
Zhang H; Soteriou B; Knowlson S; Theodoridou A; Archard LC
J Virol Methods; 1997 Dec; 69(1-2):7-17. PubMed ID: 9504746
[TBL] [Abstract][Full Text] [Related]
18. 1A and 3D gene sequences of coxsackievirus B3 strain CC: variation and phylogenetic analysis.
Liu MY; Wu DL; Liu NH; Meng QW; Meng FC
DNA Seq; 2008 Feb; 19(1):8-12. PubMed ID: 17852360
[TBL] [Abstract][Full Text] [Related]
19. Experimental CVB3-induced chronic myocarditis in two murine strains: evidence of interrelationships between virus replication and myocardial damage in persistent cardiac infection.
Andréoletti L; Hober D; Becquart P; Belaich S; Copin MC; Lambert V; Wattré P
J Med Virol; 1997 Jun; 52(2):206-14. PubMed ID: 9179770
[TBL] [Abstract][Full Text] [Related]
20. The cardiovirulent phenotype of coxsackievirus B3 is determined at a single site in the genomic 5' nontranslated region.
Tu Z; Chapman NM; Hufnagel G; Tracy S; Romero JR; Barry WH; Zhao L; Currey K; Shapiro B
J Virol; 1995 Aug; 69(8):4607-18. PubMed ID: 7609025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
